Literature DB >> 11668474

Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen.

H Iguchi1, E Onuma, K Sato, K Sato, E Ogata.   

Abstract

Cachexia often causes deterioration in the quality of life in cancer patients; however, its mechanism remains poorly understood. Cachexia has often been observed in experimental animals with bone metastases, and parathyroid hormone-related protein (PTHrP) plays an important role in the formation of such metastases. We therefore investigated the possible involvement of PTHrP in an experimental cachexia model using human lung-cancer cells (HARA-B). HARA-B cells produce a high amount of PTHrP but no TNF-alpha, IL-6 or leukemia inhibitory factor. The s.c. inoculation of HARA-B cells into nude mice caused reductions in body weight, adipose tissue weight, muscle weight and serum glucose levels. Serum levels of calcium and PTHrP increased. Neutralization of PTHrP with antibody caused rapid weight gain along with a rapid decrease in serum calcium levels. Our findings suggest that PTHrP plays an important role in the development of cancer cachexia. PTHrP therefore is a possible target molecule for the treatment of cancer cachexia. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668474     DOI: 10.1002/ijc.1425

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

Review 1.  Manipulating the environment of cancer cells in bone: a novel therapeutic approach.

Authors:  T John Martin
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 2.  Therapeutic molecular targets in human chondrosarcoma.

Authors:  Nuor Jamil; Sarah Howie; Donald M Salter
Journal:  Int J Exp Pathol       Date:  2010-10       Impact factor: 1.925

3.  Parathyroid hormone-related protein stimulates plasma renin activity via its anorexic effects on sodium chloride intake.

Authors:  Douglas K Atchison; Elizabeth Westrick; David L Szandzik; Kevin L Gordish; William H Beierwaltes
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-05-29       Impact factor: 4.310

4.  Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone.

Authors:  Tajneen Natasha; Misty Kuhn; Owen Kelly; Susan R Rittling
Journal:  Am J Pathol       Date:  2006-02       Impact factor: 4.307

5.  Effects of anti-parathyroid hormone-related protein monoclonal antibody and osteoprotegerin on PTHrP-producing tumor-induced cachexia in nude mice.

Authors:  Haruo Iguchi; Yuko Aramaki; Shigeaki Maruta; Soichi Takiguchi
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

6.  PTHrp comes full circle in cancer biology.

Authors:  Anyonya R Guntur; Casey R Doucette; Clifford J Rosen
Journal:  Bonekey Rep       Date:  2015-01-14

7.  Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia.

Authors:  Serkan Kir; James P White; Sandra Kleiner; Lawrence Kazak; Paul Cohen; Vickie E Baracos; Bruce M Spiegelman
Journal:  Nature       Date:  2014-07-13       Impact factor: 49.962

Review 8.  Anorexia in human and experimental animal models: physiological aspects related to neuropeptides.

Authors:  Mitsuhiro Yoshimura; Yasuhito Uezono; Yoichi Ueta
Journal:  J Physiol Sci       Date:  2015-06-30       Impact factor: 2.781

9.  Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated With Ipilimumab: Hormone Source and Clinical and Metabolic Correlates.

Authors:  Teresa Anne Mills; Marlana Orloff; Marina Domingo-Vidal; Paolo Cotzia; Ruth C Birbe; Rossitza Draganova-Tacheva; Maria P Martinez Cantarin; Madalina Tuluc; Ubaldo Martinez-Outschoorn
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

10.  A role for LIM kinase in cancer invasion.

Authors:  Kiyoko Yoshioka; Victoria Foletta; Ora Bernard; Kazuyuki Itoh
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.